References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. https://doi.org/10.3322/caac.21492
- Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20. https://doi.org/10.1056/NEJMoa055531
- Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 2019;393:1948-1957. https://doi.org/10.1016/S0140-6736(18)32557-1
- Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2016.
- Schmidt T, Sicic L, Blank S, Becker K, Weichert W, Bruckner T, et al. Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas. Br J Cancer 2014;110:1712-1720. https://doi.org/10.1038/bjc.2014.94
- Pedrazzani C, Sivins A, Ancans G, Marrelli D, Corso G, Krumins V, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg 2010;34:85-91. https://doi.org/10.1007/s00268-009-0288-8
- Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg 2012;255:50-58. https://doi.org/10.1097/SLA.0b013e31821d4d75
- Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 2012;255:478-485. https://doi.org/10.1097/SLA.0b013e31824857e2
- Rawicz-Pruszynski K, Cisel B, Mlak R, Mielko J, Skórzewska M, Kwietniewska M, et al. The role of the lymph node ratio in advanced gastric cancer after neoadjuvant chemotherapy. Cancers (Basel) 2019;11:1914. https://doi.org/10.3390/cancers11121914
- Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14:113-123. https://doi.org/10.1007/s10120-011-0042-4
- Zhang H, Shang X, Chen C, Gao Y, Xiao X, Tang P, et al. Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection. Oncotarget 2016;7:74337-74349. https://doi.org/10.18632/oncotarget.11188
- Zhu J, Xue Z, Zhang S, Guo X, Zhai L, Shang S, et al. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: a meta-analysis. Int J Surg 2018;57:76-83. https://doi.org/10.1016/j.ijsu.2018.08.002
- Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V, et al. Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: a multicenter retrospective study. J Surg Oncol 2019;119:948-957. https://doi.org/10.1002/jso.25411
- Li Z, Li S, Bu Z, Zhang L, Wu X, Shan F, et al. The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma. J Surg Oncol 2018;118:657-663. https://doi.org/10.1002/jso.25188
- Woo Y, Goldner B, Ituarte P, Lee B, Melstrom L, Son T, et al. Lymphadnectomy with optimum of 19 lymph nodes retrieved associated with improve survival in advanced gastric cacner: a 25,000-patient international database study. J Am Coll Surg 2017;224:546-555. https://doi.org/10.1016/j.jamcollsurg.2016.12.015
- Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, et al. Does a higher cutoff value of lymph node retrieval substantially improve survival in patients with advanced gastric cancer?-Time to embrace a new digit. Oncologist 2017;22:97-106. https://doi.org/10.1634/theoncologist.2016-0239
- Hou Y, Wang X, Chen J. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol 2018;16:198. https://doi.org/10.1186/s12957-018-1504-5
- Wohnrath DR, Araujo RL. Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol 2020;121:777-783. https://doi.org/10.1002/jso.25755
- Chu X, Yang ZF. Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer. World J Surg Oncol 2015;13:192. https://doi.org/10.1186/s12957-015-0602-x
- Hsu JT, Lin CJ, Sung CM, Yeh HC, Chen TH, Chen TC, et al. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma. Eur J Surg Oncol 2013;39:1287-1293. https://doi.org/10.1016/j.ejso.2013.07.183
- Kulig J, Sierzega M, Kolodziejczyk P, Popiela T; Polish Gastric Cancer Study Group. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 2009;96:910-918. https://doi.org/10.1002/bjs.6653
- Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-552. https://doi.org/10.1097/01.sla.0000250423.43436.e1
- Alatengbaolide LD, Lin D, Li Y, Xu H, Chen J, Wang B, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes. Am J Clin Oncol 2013;36:325-330. https://doi.org/10.1097/COC.0b013e318246b4e9
- Komatsu S, Ichikawa D, Nishimura M, Kosuga T, Okamoto K, Konishi H, et al. Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol 2017;43:203-209. https://doi.org/10.1016/j.ejso.2016.08.002
Cited by
- Lymph Node Ratio System for N Staging of Gastric Cancer: Challenging for Universal Application But Useful for the Prognostic Prediction of Individual Patients vol.21, pp.1, 2021, https://doi.org/10.5230/jgc.2021.21.e10